Focusing on prevention, diagnosis, treatment, and care monitoring during the patient journey in oncology to create value for stakeholders.
Examining the current biosimilar market.
A check on the evolving challenges and potential solutions in steering future market adoption of curative-intended treatments.
While gene therapies continue to revolutionize healthcare, uncertainty from commercialization issues still looms large.